IMMUNOMEDICS INC's ticker is and the CUSIP is 452907958. A total of 2 filers reported holding IMMUNOMEDICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $15,483,000 | +207.3% | 1,821 | +28.1% | 0.02% | +162.5% |
| Q2 2020 | $5,039,000 | +1680.6% | 1,422 | +577.1% | 0.01% | – |
| Q1 2020 | $283,000 | -86.5% | 210 | -78.8% | 0.00% | -100.0% |
| Q4 2019 | $2,092,000 | +370.1% | 989 | +194.3% | 0.01% | +400.0% |
| Q3 2019 | $445,000 | +0.5% | 336 | +5.0% | 0.00% | 0.0% |
| Q2 2019 | $443,000 | -17.5% | 320 | +14.3% | 0.00% | 0.0% |
| Q1 2019 | $537,000 | -82.5% | 280 | -87.0% | 0.00% | -88.9% |
| Q4 2018 | $3,069,000 | +25.4% | 2,151 | +83.1% | 0.01% | +12.5% |
| Q3 2018 | $2,447,000 | -29.7% | 1,175 | -20.1% | 0.01% | -42.9% |
| Q2 2018 | $3,479,000 | +1460.1% | 1,470 | -28.7% | 0.01% | +40.0% |
| Q1 2018 | $223,000 | +209.7% | 2,063 | +51.5% | 0.01% | +233.3% |
| Q4 2017 | $72,000 | +213.0% | 1,362 | +119.7% | 0.00% | +200.0% |
| Q3 2017 | $23,000 | +43.8% | 620 | +31.1% | 0.00% | 0.0% |
| Q2 2017 | $16,000 | -79.2% | 473 | -71.1% | 0.00% | -66.7% |
| Q1 2017 | $77,000 | +413.3% | 1,634 | +132.8% | 0.00% | +200.0% |
| Q4 2016 | $15,000 | -44.4% | 702 | -0.3% | 0.00% | -50.0% |
| Q3 2016 | $27,000 | -75.2% | 704 | -32.4% | 0.00% | -71.4% |
| Q2 2016 | $109,000 | +303.7% | 1,042 | +19.5% | 0.01% | +250.0% |
| Q1 2016 | $27,000 | +68.8% | 872 | +64.8% | 0.00% | +100.0% |
| Q4 2015 | $16,000 | -91.2% | 529 | +19.7% | 0.00% | -92.3% |
| Q3 2015 | $182,000 | +184.4% | 442 | +11.6% | 0.01% | +160.0% |
| Q2 2015 | $64,000 | +814.3% | 396 | +970.3% | 0.01% | +400.0% |
| Q1 2015 | $7,000 | -22.2% | 37 | -22.9% | 0.00% | 0.0% |
| Q4 2014 | $9,000 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|